Free tool
Stocks listed on Nasdaq GM
We cover 55 companies listed on Nasdaq GM. The median market value in the group is $4.46B. Across the group, the median move over the past trading day is +1.05%. 67% of the 55 with a 200-day average trade above it. Price change over the past year runs from −42.8% to +265.5% across the middle 80 percent of the group, with a median of +57.0%.
Other lists in this group
Table
55 of 701 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| MDB | MongoDB, Inc. | $32.57B | Large cap | +85.37% | Sep 1, 2026 |
| SITM | SiTime Corporation | $17.87B | Large cap | +156.49% | Nov 4, 2026 |
| IESC | IES Holdings, Inc. | $12.48B | Large cap | −11.51% | Nov 20, 2026 |
| AXSM | Axsome Therapeutics, Inc. | $10.76B | Large cap | +76.67% | Nov 2, 2026 |
| SMMT | Summit Therapeutics Inc. | $10.66B | Large cap | −49.14% | Oct 19, 2026 |
| KYMR | Kymera Therapeutics, Inc. | $10.53B | Large cap | +202.82% | Nov 3, 2026 |
| ABVX | ABIVAX Société Anonyme | $10.29B | Large cap | +52.25% | Sep 21, 2026 |
| APGE | Apogee Therapeutics, Inc. | $10.21B | Large cap | +265.05% | Nov 9, 2026 |
| PTGX | Protagonist Therapeutics, Inc. | $10.01B | Large cap | +164.75% | Nov 5, 2026 |
| AAOI | Applied Optoelectronics, Inc. Common Stock | $9.61B | Mid cap | +364.87% | Nov 5, 2026 |
| APPF | AppFolio, Inc. | $7.90B | Mid cap | −18.83% | Oct 29, 2026 |
| RYTM | Rhythm Pharmaceuticals, Inc. | $7.78B | Mid cap | +14.26% | Nov 3, 2026 |
| CAMT | Camtek Ltd. | $6.84B | Mid cap | +77.60% | Nov 16, 2026 |
| ORKA | Oruka Therapeutics, Inc. | $6.74B | Mid cap | +601.72% | Nov 11, 2026 |
| LNTH | Lantheus Holdings, Inc. | $6.58B | Mid cap | +79.61% | Nov 5, 2026 |
| TTD | The Trade Desk, Inc. | $6.23B | Mid cap | −74.70% | Nov 5, 2026 |
| TVTX | Travere Therapeutics, Inc. | $6.06B | Mid cap | +288.91% | Oct 29, 2026 |
| RDNT | RadNet, Inc. | $6.05B | Mid cap | +10.45% | Nov 5, 2026 |
| MIRM | Mirum Pharmaceuticals, Inc. | $5.98B | Mid cap | +36.58% | Nov 4, 2026 |
| XENE | Xenon Pharmaceuticals Inc. | $5.85B | Mid cap | +58.42% | Nov 2, 2026 |
| LGND | Ligand Pharmaceuticals Incorporated | $5.62B | Mid cap | +77.42% | Nov 5, 2026 |
| ACMR | ACM Research, Inc. | $5.56B | Mid cap | +176.98% | Nov 4, 2026 |
| RUM | RUM Group Inc. | $5.07B | Mid cap | +35.32% | Nov 9, 2026 |
| ENPH | Enphase Energy, Inc. | $4.92B | Mid cap | −2.30% | Oct 27, 2026 |
| USAR | USA Rare Earth, Inc. | $4.75B | Mid cap | +22.62% | Nov 5, 2026 |
| OLLI | Ollie's Bargain Outlet Holdings, Inc. | $4.51B | Mid cap | −42.68% | Aug 27, 2026 |
| RLAY | Relay Therapeutics, Inc. | $4.51B | Mid cap | +486.04% | Nov 5, 2026 |
| DAVE | Dave Inc. | $4.46B | Mid cap | +76.49% | Nov 4, 2026 |
| TNGX | Tango Therapeutics, Inc. | $4.13B | Mid cap | +264.73% | Nov 4, 2026 |
| IOVA | Iovance Biotherapeutics, Inc. | $3.82B | Mid cap | +233.60% | Nov 5, 2026 |
| FLY | Firefly Aerospace Inc. | $3.73B | Mid cap | −50.23% | Nov 11, 2026 |
| FRPT | Freshpet, Inc. | $3.62B | Mid cap | +33.95% | Nov 2, 2026 |
| GPCR | Structure Therapeutics Inc. | $3.56B | Mid cap | +168.82% | Nov 5, 2026 |
| NAMS | NewAmsterdam Pharma Company N.V. | $3.27B | Mid cap | +10.69% | Nov 4, 2026 |
| TMDX | TransMedics Group, Inc. | $3.23B | Mid cap | −18.59% | Oct 29, 2026 |
| SOUN | SoundHound AI, Inc. | $3.13B | Mid cap | −41.78% | Nov 5, 2026 |
| ZLAB | Zai Lab Limited | $2.94B | Mid cap | −23.10% | Nov 5, 2026 |
| APPN | Appian Corporation | $2.84B | Mid cap | +35.97% | Nov 5, 2026 |
| ATAI | AtaiBeckley Inc. | $2.74B | Mid cap | +56.96% | Nov 12, 2026 |
| NRIX | Nurix Therapeutics, Inc. | $2.73B | Mid cap | +178.70% | Oct 8, 2026 |
| LUNR | Intuitive Machines, Inc. | $2.66B | Mid cap | +87.36% | Nov 10, 2026 |
| SUPN | Supernus Pharmaceuticals, Inc. | $2.62B | Mid cap | +2.09% | Nov 3, 2026 |
| DJT | Trump Media & Technology Group Corp. | $2.61B | Mid cap | −45.41% | Nov 6, 2026 |
| VERA | Vera Therapeutics, Inc. | $2.54B | Mid cap | +65.32% | Nov 5, 2026 |
| KOD | Kodiak Sciences Inc. | $2.48B | Mid cap | +316.68% | Nov 12, 2026 |
| ATRC | AtriCure, Inc. | $2.48B | Mid cap | +28.65% | Oct 27, 2026 |
| RAPP | Rapport Therapeutics, Inc. | $2.46B | Mid cap | +249.76% | Nov 5, 2026 |
| PAYO | Payoneer Global Inc. | $2.41B | Mid cap | +4.87% | Nov 4, 2026 |
| OCUL | Ocular Therapeutix, Inc. | $2.39B | Mid cap | −8.34% | Nov 4, 2026 |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.27B | Mid cap | +4.09% | Nov 3, 2026 |
| URGN | UroGen Pharma Ltd. | $2.27B | Mid cap | +150.59% | Nov 5, 2026 |
| VERX | Vertex, Inc. | $2.19B | Mid cap | −46.69% | Nov 2, 2026 |
| XNCR | Xencor, Inc. Common Stock | $2.18B | Mid cap | +265.79% | Nov 4, 2026 |
| KEEL | Keel Infrastructure Corp. | $2.17B | Mid cap | +183.06% | Nov 9, 2026 |
| ADMA | ADMA Biologics, Inc. | $2.14B | Mid cap | −42.86% | Nov 4, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.